Resultados da busca - Anagnostou, Valsamo

Primary parotid adenocarcinoma metastasis to the spleen with PIK3CA mutation: cytological findings and review of the literature por Inouye, Casey M, Anagnostou, Valsamo, Li, Qing Kay

Obter o texto integral Obter o texto integral

Modeling Prognostic Factors in Resectable Pancreatic Adenocarcinomas por Botsis, Taxiarchis, Anagnostou, Valsamo K., Hartvigsen, Gunnar, Hripcsak, George, Weng, Chunhua

Obter o texto integral Obter o texto integral

Developing a Multivariable Prognostic Model for Pancreatic Endocrine Tumors Using the Clinical Data Warehouse Resources of a Single Institution por Botsis, Taxiarchis, Anagnostou, Valsamo K., Hartvigsen, Gunnar, Hripcsak, George, Weng, Chunhua

Obter o texto integral Obter o texto integral Obter o texto integral

Standardization of Epidermal Growth Factor Receptor (EGFR) Measurement by Quantitative Immunofluorescence and Impact on Antibody-Based Mutation Detection in Non–Small Cell Lung Can... por Dimou, Anastasios, Agarwal, Seema, Anagnostou, Valsamo, Viray, Hollis, Christensen, Stephen, Gould Rothberg, Bonnie, Zolota, Vassiliki, Syrigos, Konstantinos, Rimm, David L.

Obter o texto integral Obter o texto integral Obter o texto integral

Antibody validation por Bordeaux, Jennifer, Welsh, Allison W., Agarwal, Seema, Killiam, Elizabeth, Baquero, Maria T., Hanna, Jason A., Anagnostou, Valsamo K., Rimm, David L.

Obter o texto integral Obter o texto integral Obter o texto integral

Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity por Anagnostou, Valsamo, Yarchoan, Mark, Hansen, Aaron R., Wang, Hao, Verde, Franco, Sharon, Elad, Collyar, Deborah, Chow, Laura Q.M., Forde, Patrick M.

Obter o texto integral Obter o texto integral Obter o texto integral

Analytic Variability in Immunohistochemistry Biomarker Studies por Anagnostou, Valsamo K., Welsh, Allison W., Giltnane, Jennifer M., Siddiqui, Summar, Liceaga, Camil, Gustavson, Mark, Syrigos, Konstantinos N., Reiter, Jill L., Rimm, David L.

Obter o texto integral Obter o texto integral Obter o texto integral

Multi-Level Targeting of the Phosphatidylinositol-3-Kinase Pathway in Non-Small Cell Lung Cancer Cells por Zito, Christopher R., Jilaveanu, Lucia B., Anagnostou, Valsamo, Rimm, David, Bepler, Gerold, Maira, Sauveur-Michel, Hackl, Wolfgang, Camp, Robert, Kluger, Harriet M., Chao, Herta H.

Obter o texto integral Obter o texto integral Obter o texto integral

Quantitative Assessment of Effect of Preanalytic Cold Ischemic Time on Protein Expression in Breast Cancer Tissues por Neumeister, Veronique M., Anagnostou, Valsamo, Siddiqui, Summar, England, Allison Michal, Zarrella, Elizabeth R., Vassilakopoulou, Maria, Parisi, Fabio, Kluger, Yuval, Hicks, David G., Rimm, David L.

Obter o texto integral Obter o texto integral Obter o texto integral

Differential sensitivity to platinum-based chemotherapy in primary uterine serous papillary carcinoma cell lines with high versus low HER-2/neu expression in vitro por Cross, Sarah N., Cocco, Emiliano, Bellone, Stefania, Anagnostou, Valsamo K., Brower, Stacey L., Richter, Christine E., Siegel, Eric R., Schwartz, Peter E., Rutherford, Thomas J., Santin, Alessandro D.

Obter o texto integral Obter o texto integral Obter o texto integral

Programmed death ligand-1 expression in non-small cell lung cancer por Velcheti, Vamsidhar, Schalper, Kurt A, Carvajal, Daniel E, Rimm, David L, Anagnostou, Valsamo K, Syrigos, Konstantinos N, Sznol, Mario, Herbst, Roy S, Gettinger, Scott N, Chen, Lieping, Syrigos, Konstantinos N

Obter o texto integral Obter o texto integral Obter o texto integral

Artificial intelligence-assisted serial analysis of clinical cancer genomics data identifies changing treatment recommendations and therapeutic targets por Fischer, Catherine G., Pallavajjala, Aparna, Jiang, LiQun, Anagnostou, Valsamo, Tao, Jessica, Adams, Emily, Eshleman, James R., Gocke, Christopher D., Lin, Ming-Tseh, Platz, Elizabeth A., Xian, Rena R.

Obter o texto integral Obter o texto integral Obter o texto integral

Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor-Positive Metastatic Breast Cancer: a Randomized Phase II Study por Osborne, C. Kent, Neven, Patrick, Dirix, Luc Y., Mackey, John R., Robert, Jean, Underhill, Craig, Schiff, Rachel, Gutierrez, Carolina, Migliaccio, Ilenia, Anagnostou, Valsamo K., Rimm, David L., Magill, Patrick, Sellers, Mark

Obter o texto integral Obter o texto integral Obter o texto integral

A Tissue Quality Index – an Intrinsic Control for Measurement of Effects of Pre-analytical Variables on FFPE Tissue por Neumeister, Veronique M., Parisi, Fabio, England, Allison M., Siddiqui, Summar, Anagnostou, Valsamo, Zarrella, Elizabeth, Vassilakopolou, Maria, Bai, Yalai, Saylor, Sasha, Sapino, Anna, Kluger, Yuval, Hicks, David G., Bussolati, Gianni, Kwei, Stephanie, Rimm, David L.

Obter o texto integral Obter o texto integral Obter o texto integral

High-throughput prediction of MHC class I and class II neoantigens with MHCnuggets por Shao, Xiaoshan M., Bhattacharya, Rohit, Huang, Justin, Sivakumar, I.K. Ashok, Tokheim, Collin, Zheng, Lily, Hirsch, Dylan, Kaminow, Benjamin, Omdahl, Ashton, Bonsack, Maria, Riemer, Angelika B., Velculescu, Victor E., Anagnostou, Valsamo, Pagel, Kymberleigh A., Karchin, Rachel

Obter o texto integral Obter o texto integral Obter o texto integral

High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology por Anagnostou, Valsamo K, Lowery, Frank J, Zolota, Vassiliki, Tzelepi, Vassiliki, Gopinath, Arun, Liceaga, Camil, Panagopoulos, Nikolaos, Frangia, Konstantina, Tanoue, Lynn, Boffa, Daniel, Gettinger, Scott, Detterbeck, Frank, Homer, Robert J, Dougenis, Dimitrios, Rimm, David L, Syrigos, Konstantinos N

Obter o texto integral Obter o texto integral Obter o texto integral

Personalized genomic analyses for cancer mutation discovery and interpretation por Jones, Siân, Anagnostou, Valsamo, Lytle, Karli, Parpart-Li, Sonya, Nesselbush, Monica, Riley, David R., Shukla, Manish, Chesnick, Bryan, Kadan, Maura, Papp, Eniko, Galens, Kevin G., Murphy, Derek, Zhang, Theresa, Kann, Lisa, Sausen, Mark, Angiuoli, Samuel V., Diaz, Luis A., Velculescu, Victor E.

Obter o texto integral Obter o texto integral Obter o texto integral

GOLPH3 modulates mTOR signaling and rapamycin sensitivity in cancer por Scott, Kenneth L., Kabbarah, Omar, Liang, Mei-Chih, Ivanova, Elena, Anagnostou, Valsamo, Wu, Joyce, Dhakal, Sabin, Wu, Min, Chen, Shujuan, Feinberg, Tamar, Huang, Joseph, Saci, Abdel, Widlund, Hans R., Fisher, David E., Xiao, Yonghong, Rimm, David L., Protopopov, Alexei, Wong, Kwok-Kin, Chin, Lynda

Obter o texto integral Obter o texto integral Obter o texto integral

A machine learning approach for somatic mutation discovery por Wood, Derrick E., White, James R., Georgiadis, Andrew, Van Emburgh, Beth, Parpart-Li, Sonya, Mitchell, Jason, Anagnostou, Valsamo, Niknafs, Noushin, Karchin, Rachel, Papp, Eniko, McCord, Christine, LoVerso, Peter, Riley, David, Diaz, Luis A., Jones, Siân, Sausen, Mark, Velculescu, Victor E., Angiuoli, Samuel V.

Obter o texto integral Obter o texto integral Obter o texto integral

Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma—a phase 3 randomised trial por Kok, Peey Sei, Forde, Patrick M, Hughes, Brett, Sun, Zhuoxin, Brown, Chris, Ramalingam, Suresh, Cook, Alistair, Lesterhuis, Willem Joost, Yip, Sonia, O’Byrne, Ken, Pavlakis, Nick, Brahmer, Julie, Anagnostou, Valsamo, Ford, Kate, Fitzpatrick, Karen, Bricker, Alison, Cummins, Michelle M, Stockler, Martin, Nowak, Anna K

Obter o texto integral Obter o texto integral Obter o texto integral